Coronavirus in Mexico as of April 13: Health recorded 592 more deaths from COVID-19

Until Monday April 13 They registered 210,294 deaths caused by coronavirus disease in Mexico. This means that in the last 24 hours they have been added 592 new deaths in national statistics.

This was announced by José Luis Alomía, director of epidemiology, during an evening press conference, which also detailed that from week 12 to 13 of 2021 a 15% decrease in estimated cases (sum of confirmed and suspected infections) nationally, including 2,477,729 until the last cut. In addition, 1,815,237 people have recovered from the disease.

On the other hand, it has been reported that there is 27,254 (1%) active infections, which represents people who have had symptoms in the previous 14 days.

According to the official, it was recorded 18% bed occupancy nationwide (both general care and ventilator).

According to the Serious Acute Respiratory Infections Network (SARI), there are 26392 general beds available Yes 5 233 busy. While with a fan there is an availability of 8,888 places accessible to patients before the 2,263 that are saturated.

The technical report of the SSa mentions that on April 13 the antigen was injected into 399,070 people, cumulating 12,252,769 doses applied since December 24, 2020. In addition, the number of vaccines lost amounts to a total of 7,523 (0.06%).

Primary care personnel for patients infected with the SARS-CoV-2 virus:

– First doses: 156351

– Full plan: 756962

The elderly:

– First doses: 7,494,086

– Full plan: 1,776,130

Educational staff:

– First doses: 5,307

– Full speed: 17627

In addition, they reported 15,019 (0.1%) events presumed to be associated with vaccination or immunization were reported. Of this total, 13,290 correspond to vaccine manufactured by Pfizer-BioNTech, 849 to AstraZeneca and Oxford University antigen, 577 to SinoVac, 221 to Sputnik V, 75 to CanSino, four to unknown antigens and 3 resulting from immunization in foreigners.

Among the cases enumerated, only 1% (177 patients) presented serious complications related to the application of the antigen. In addition, it was detailed that at present, only 55 people are hospitalized.

16,900,850 doses of the vaccine arrived in Mexico to prevent infection against SARS-CoV-2, of which 6,971,250 correspond to Pfizer-BioNTech, 3,589,300 to AstraZeneca, 4 million to SinoVac, 900,000 to Sputnik V and 1,440,300 to CansinoBio.

The Under-Secretary for Prevention and Health Promotion Hugo lopez-gatell reminded that Mexico was the first country in Latin America to apply the vaccine that prevents infection with SARS-CoV-2.

He explained that the goal of this strategy is to reduce mortality caused by the disease, a goal that will be achieved if the most vulnerable groups of people are vaccinated against the coronavirus disease.

“If we organize the population by age, starting with the oldest people, as most countries that use COVID-19 vaccines do, then we will reduce mortality, the most undesirable result of this epidemic», Details the official.

On the other hand, the undersecretary assured that In Mexico, a vaccination program with doses produced by different pharmaceutical companies will not be applied. He stressed that if the effectiveness of this modality is not proven, its use in the country will be avoided.

MORE ON THIS TOPIC: